Medtronic plc
Medtronic sells medical devices in several lines, among them cardiac, diabetes, surgery and neuro. Abbott, Boston Scientific and Stryker sell parts of the same trade. It is not the world leader by decree and it is not a rising dividend counted in years. This report does not describe how the device is used.
The hospital can order the next one from someone else. Changing equipment is a project. The lines do not move together. A product withdrawal, or a year of a thin hospital budget, is not normal earnings.
Cash is that sale. The dividend has to fit. It is not a device the surgeon cannot leave.
"The advantage is the hospital that already buys that line and the team that already knows it. They can order the next one elsewhere. The moat narrows if the budget falls, or if one line is withdrawn and the others do not make it up."
Loading the Vaultflake…
—
Health is the debt of several lines, not of a device that is never changed. Quality separates the margin of one line from another. Growth follows sales to the hospital, not a year of a high budget. P/E is read against a year of many sales, not against that peak. Shareholder return is the dividend, checked against cash. Do not read it as a dividend record already closed.
The P/E of a year of many sales is not the earnings if the hospital delays the purchase. EV/EBITDA is read without treating one line as if the others could not soften. Do not use a drug company's multiple, which collects the prescription, as if the device and the drug were the same book. A dash if the MDT cache is cold.
Not advice on Medtronic. Vaultflake does not describe how the device is used and does not count years of dividends. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
The advantage is the hospital that already buys that line and the team that already knows it. They can order the next one elsewhere. The moat narrows if the budget falls, or if one line is withdrawn and the others do not make it up.
Health is the debt of several lines, not of a device that is never changed. Quality separates the margin of one line from another. Growth follows sales to the hospital, not a year of a high budget. P/E is read against a year of many sales, not against that peak. Shareholder return is the dividend, checked against cash. Do not read it as a dividend record already closed.
The P/E of a year of many sales is not the earnings if the hospital delays the purchase. EV/EBITDA is read without treating one line as if the others could not soften. Do not use a drug company's multiple, which collects the prescription, as if the device and the drug were the same book. A dash if the MDT cache is cold.
Not advice on Medtronic. Vaultflake does not describe how the device is used and does not count years of dividends. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Health Care · Pharmaceuticals and Medical Devices
Health Care · Diabetes and Obesity Medicines
Health Care · Insurance and Optum
Health Care · Diabetes and Obesity Medicines
Health Care · Immunology
Health Care · Oncology
A free account opens the interactive chart. The Vault assistant is Premium.